FDA Investigator Neal L Adams
Neal L Adams has conducted inspections on 23 sites in 9 countries as of 23 Mar 2015. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
23 Mar 2015
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
Norway,
India,
Singapore,
United States of America,
France,
Ireland,
Germany,
Taiwan
FDA Investigators that have inspected at least one site in common with Neal L Adams:
Adam R Cooke,
Alan E Mehl,
Alan L Brend,
Alan L Truong,
Amy E Devine,
Anita Narula, PhD,
Anita R Michael,
Ann L Demarco,
Anthony R Bucks,
Aref Mel Demerdash,
Arthur S Williams, Jr,
Ashar P Parikh,
Barbara I Rogolsky,
Bijoy Panicker,
Brandon C Heitmeier,
Brenda C Hamilton,
Brenda W Uratani, PhD,
Brett R Havranek,
Brittany D Terhar,
Bryan A Galvez,
Bryan S Roddy,
Burnell M Henry,
Carl A Huffman, III,
Carl J Montgomery,
Carl Lee,
Charles M Edwards,
Charles R Cote, RIC,
Chilton L Ng,
Chris A Sack,
Christina Capacci Daniel, PhD,
Christopher T Peters,
Cody D Rickman,
Concepcion Cruz, Jr,
Constance Y Fears,
Cynthia L Evitt,
Cynthia M Goudeau,
Danial S Hutchison,
Daniel R Hurt,
David A Place,
David J Eide,
David J Gomes,
Diane L Raccasi,
Douglas C Kovacs,
Dr. Sriram Subramaniam, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edward E Lockwood (EEL),
Emest F Bizjak,
Eric M Mueller, PharmD,
Eric M Padgett,
Erika V Butler,
Evelyne L Weaver,
Farhana Khan,
Felix Maldonado,
Gayle S Lawson,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Ingrid Y Johnson,
J Michael Cannon, PhD,
James C Maclaughlin,
James D Planchon,
James I Giefer,
James L Dunnie, Jr,
Javier O Vega,
Jawaid Hamid,
Jeannie M Vonderbrink,
Jeffrey A Sommers,
Jill J Tillman,
Joey V Quitania,
Jose Acruz Gonzalez,
Jose M Cayuela,
Jose R Hernandez,
Jose Velez,
Joseph R Lambert,
Julie N Vosilus,
Karen C Daugherty,
Kejun Cheng,
Kellia N Hicks,
Kelvin Cheung,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberly Lewandowski Walker,
LCDR Debra Emerson,
Linda R Kuchenthal,
Lisa L Flores,
Lisa L Gilliam,
LT Richard A Lyght,
Marcus F Yambot,
Maria Estrella,
Marijo B Kambere, PhD,
Marion D Wimberly, Jr,
Mark S Ross,
Martin K Yau, PhD,
Matthew D Schnittker,
Matthew H Hunt,
Matthew R Sleeter,
Megan M Kirk,
Megan T Ziegler,
Michael A Charles,
Michael C Zubelewicz,
Michael D Smedley,
Michael E Maselli,
Michael R Klapal,
Michael S Smoker,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Obert,
Michele Perry Williams,
Miguel A Martinez Perez,
Mindy M Chou,
Minerva Rogers,
Miranda D Mcdonald,
Monique M Brooks,
Mra B Kamberem,
Mra Davism,
Mra V Millarw,
Muralidhara B Gavini, PhD,
Nancy G Schmidt,
Omotunde O Osunsanmi,
Pamela N Agaba,
Patrick L Wisor,
Paul E Stein,
Peter C Chow,
Peter E Baker,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Rachel Collen,
Ralph H Vocque,
Ralph Jerndal,
Randy D Moore,
Raymond Valdivia,
Rebecca Rodriguez,
Regina T Brown,
Richard K Vogel,
Rita K Kabaso,
Robert J Ham,
Robin K Hatfield,
Robin K Reel,
Rodney D Combs,
Rosanna M Goodrich,
Ruth Moore, PhD,
Samuel K Gibbons, Jr,
Santos E Camara,
Seneca D Toms,
Shafiq S Ahadi,
Sharon K Thoma, PharmD,
Shawn E Larson,
Shirley J Berryman,
Shwnji Susie Lee,
Sony Mathews,
Stacie A Woods,
Stephen C Smith,
Stephen D Brown,
Stephen J Kilker,
Steven D Kehoe,
Steven Fong, MS, PhD,
Susan F Laska, MS,
Susan T Hadman,
Susanna E Ford,
Susie H Lee,
Tamara J Umscheid,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Thomas J Arista,
Tonya R Johnson,
Torrey M Ward,
Travis S Bradley,
Veronica Fuentes, MS,
Victoria A Wagoner,
Vinh T Phan,
Warren J Lopicka,
Wayne D Mcgrath,
Wendy G Tan, PhD,
Xiaokuang Lai, PhD,
Yehualashet A Gessesse,
Yumi J Hiramine,
Yvins Dezan,
Zachary A Bogorad,
Zhong Li, PhD,
Zi Qiang Gu
Neal L Adams's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2004 | EIR | Catalent CTS, LLC - EIR, 2004-04-02 |
April, 2014 | FDA 483 | Hikal Limited - Form 483, 2014-04-11 |
November, 2005 | EIR | Catalent CTS, LLC - EIR, 2005-11-22 |
January, 2008 | FDA 483 | Teva Pharmaceuticals USA Inc - Form 483, 2008-01-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more